Candel Therapeutics Inc (CADL) earnings · rev $125.0K
These earnings events as JSON? API free 100/dayCandel Therapeutics Inc (CADL) is a biotechnology company listed on NASDAQ.
This CADL earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported CADL revenue for 2022-12-31 was $125.0K. Net income was -$18.8M. CADL currently screens at market cap $592.0M.
When the next CADL 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for CADL. We will not invent a beat or miss.
Not investment advice. Full CADL research stays on the stock page; the tape stays on the quote page.
CADL earnings FAQ
What are CADL's latest revenue and net income?
Latest cached Candel Therapeutics Inc (CADL) revenue for Dec 31, 2022 was $125.0K. Net income was -$18.8M. Statements: https://lician.com/financials/cadl
What is CADL's latest diluted EPS?
Latest cached Candel Therapeutics Inc (CADL) diluted EPS for Dec 31, 2022 was -$0.65.
What period does the latest CADL earnings print cover?
The latest cached Candel Therapeutics Inc (CADL) earnings print covers Dec 31, 2022.
Where are CADL earnings listed?
Cached earnings facts for Candel Therapeutics Inc (CADL) are listed at https://lician.com/earnings/cadl. Statements: https://lician.com/financials/cadl
Not investment advice.